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Controlled slow-freezing is the procedure currently applied for immature testicular tissue
(ITT) cryobanking in clinical practice. Vitrification has been proposed as a promising alter-
native, with a view to better preserve the spermatogonial stem cells for future fertility
restoration by autografting in young boys suffering from cancer. It appears that besides the
potential influence of the cryopreservation technique used, the transplantation procedure
itself has a significant impact on spermatogonial loss observed in ITT xenografts. Eighteen
ITT pieces issued from 6 patients aged 2–15 years were used. Fragments of fresh tissue
(serving as ungrafted controls), frozen-thawed tissue, frozen-thawed tissue supplemented
with N -acetylcysteine (NAC), and frozen-thawed tissue supplemented with testosterone
xenografted to nude mice for 5 days were compared. Upon graft removal, histological and
immunohistochemical analyses were performed to evaluate spermatogonia, intratubular
proliferation, and intrinsic and extrinsic apoptosis. A significant decrease in the integrity
of intact seminiferous tubules was found in all three grafted groups. Spermatogonia were
observed by immunohistochemistry in all grafted groups, with recovery rates of 67, 63,
and 53%, respectively, for slow-frozen tissue, slow-frozen tissue supplemented with NAC,
and slow-frozen tissue supplemented with testosterone. Apoptosis evidenced by active
caspase-3 and terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling was
similar in all grafts.The study is limited by the low availability of ITT samples of human origin,
and no clear impact of graft supplementation was found. The mouse xenotransplantation
model needs to be refined to investigate human spermatogenesis in human ITT grafts.
Keywords: cryopreservation, fertility preservation, immature testicular tissue, spermatogonia, supplemented
xenografting
INTRODUCTION
Gonadotoxic treatments used for childhood cancer therapy can
irreversibly affect fertility in adulthood. With increased effective-
ness of these cancer treatments, ≥80% of patients survive their
disease (1–3), so finding techniques to preserve fertility has become
a priority quality-of-life issue. While sperm can be cryopreserved
in adolescent boys and adults, this is not an option for young
boys, since no spermatozoa are produced before puberty. However,
cryopreservation of immature testicular tissue (ITT) containing
spermatogonial stem cells (SSCs) can be offered to these prepu-
bertal patients, with a view to future autotransplantation or in vitro
maturation.
In human beings, evaluation of cryopreservation techniques
for ITT has been done through a mouse xenotransplantation
model. Although studies show promising results with survival of
spermatogonia (SG) and initiation of spermatogenesis, the recov-
ery rate of these SG appears to be greatly reduced, regardless of
grafting site or follicle-stimulating hormone (FSH) supplemen-
tation (4–8). Moreover, SG loss was found to increase over time,
with SG recovery rates of 14.5 and 3.7%, at 3 weeks and 6 months,
respectively, for slow-frozen/thawed and xenografted tissue (4, 5).
Other methods like vitrification, which could minimize cell
and tissue damage due to ice crystal formation inherent to the
slow-freezing technique, could be more efficient at preserving SG.
In an attempt to improve cryopreservation techniques for SG
preservation, slow-freezing and vitrification of ITT were compared
after xenografting. Interestingly, both cryopreservation protocols
resulted in similar SG survival rates (8), suggesting that etiolo-
gies other than the cryopreservation procedure may be implicated
in SG loss. Oxidative stress due to hypoxia related to the avas-
cular xenografting technique and/or an inadequate endocrine or
paracrine host environment may be involved.
Indeed, ischemic stress can lead to tissue apoptosis or necro-
sis in grafts, as seen in transplanted ovarian tissue (9). Extensive
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apoptosis enhanced with active caspase-3 and increased numbers
of terminal deoxynucleotidyl transferase-mediated dUTP nick end
labeling (TUNEL)-positive cells were also previously observed in
ITT transplanted for 3 days [unpublished data, Wyns, PhD the-
sis (10)]. It was established that during revascularization of tissue
grafts, hypoxia occurs during the first 5 days, followed by progres-
sive reoxygenation after this period (11). Addition of antioxidants
to protect the graft during these first 5 days has, therefore, been
considered to limit oxidative stress before revascularization.
N -acetylcysteine (NAC) is a good antioxidant candidate, hav-
ing been used in clinical practice since 1970 as an antidote to
acetaminophen intoxication (12), as well as in other clinical set-
tings such as cancer, chronic obstructive pulmonary disease, cystic
fibrosis, some infections, and contrast-induced nephropathy (13–
15). N -acetylcysteine acts as an antioxidant preventing apoptosis
by replenishing intracellular glutathione (GSH). By regenerating
the pool of GSH, NAC protects cells from oxidative stress caused
by reactive oxygen species (ROS) and reduces cell membrane lipid
peroxidation. A protective effect of NAC on the tissue in case of
testicular torsion/distortion (16–18) and apoptosis inhibition in
germ cell cultures (19) have been shown.
The role of the hormonal environment for maintenance and
development of the graft was also found to be key, emphasized
by the finding that grafted tissue endocrine function is extrinsi-
cally modulated by the recipient mouse hypothalamic–pituitary–
gonadal axis (20). However, the benefits of gonadotropin adminis-
tration appear to be controversial. While administration of exoge-
nous gonadotropins to mice led to improved tissue maturation
and differentiation in pig and monkey xenografts (21, 22), this
beneficial effect was not observed in xenografted testicular tissue
from marmosets or horses (23, 24), nor cryopreserved and grafted
human ITT (7). The influence of testosterone on xenograft out-
come has not yet been investigated, even though testosterone is
a key paracrine factor in spermatogenesis (25) and was found to
reduce apoptosis of germ cells in cell cultures (26).
The objective of our study was, therefore, to evaluate the effect
of the addition of NAC or testosterone to human slow-frozen
ITT xenografts in terms of SG recovery, cell proliferation, and
apoptosis.
MATERIALS AND METHODS
STUDY DESIGN
Eighteen ITT pieces (1 mm3) were obtained from six prepuber-
tal patients (2–15 years of age). The tissues pieces were slow-
frozen, thawed,and allocated to three different mouse xenografting
groups: (A) control, (B) supplemented with NAC, and (C) supple-
mented with testosterone and FSH. Fragments of fresh tissue fixed
in a 4% paraformaldehyde (PFA 4%, VWR Chemicals, Leuven,
Belgium) solution served as ungrafted controls.
In group A, the mice received 200µl of phosphate-buffered
saline (PBS, Sigma Aldrich, Bornem, Belgium) by intraperitoneal
(IP) injection on day 0 and day 2. In group B, the tissue was
placed in a bath (5 ml) of Hank’s balanced salt solution (HBSS,
Gibco, Merelbeke, Belgium) with 30 mg of NAC (Sigma Aldrich)
for 5 min at 4°C before grafting. On day 2, the mice received
an IP injection of 200µl of NAC (150 mg/kg/bodyweight). In
group C, the mice were given testosterone (Fagron, Waregem,
Belgium) (5 mg/kg) by intramuscular (IM) injection on day 0
and day 2 after dilution in vegetal oil, sterilized by filtration. As
exogenous testosterone administration induces inhibition of the
hypothalamic–pituitary–gonadal axis by negative feedback, 1.5 IU
FSH (27) was concomitantly administered to maintain Sertoli cell
stimulation. After 5 days, the grafts were recovered and fixed in PFA
4% solution, embedded in paraffin, and cut into serial sections for
analysis by histology and immunohistochemistry.
ANIMALS
Nine NMRI nu/nu mice (Janvier Laboratories, Le Genest-St-Isle,
France) aged 8 weeks were used as recipients for the xenografts.
They were housed in cages under filtered hoods (MicroIsolator,
Uno) in rooms maintained at an ambient temperature between 22
and 24°C with a day/night cycle of 12 h. All housing material and
food were autoclaved before use. The mice were fed ad libitum on
laboratory chow (complete food for rats and mice; Pavan Carfil)
and acidified water. All experiments in this study were approved by
the Ethics Review Board and the Committee on Animal Research
of the Catholic University of Louvain.
DONOR TESTICULAR TISSUE
Immature testicular tissue was retrieved from six boys aged
between 2 and 15 years (2, 2, 8, 9, 14, and 15 years) after obtaining
informed consent from the parents and the child’s ascent (where
applicable). Sample size was small because of the scarcity of human
ITT. Patients were referred by pediatric oncologists or hematol-
ogists to a reproductive specialist in fertility preservation when
they considered that the risk of infertility due to treatment was
high and/or the parents specifically requested fertility preserva-
tion techniques. All donors were scheduled for testicular biopsy
prior to gonadotoxic treatment. Unilateral testicular sampling of
less than 5% of total testicular volume (based on theoretical size
by age from 0 to 12) (28) was performed by a pediatric urologist
through a scrotal incision. The ethics committee agreed to testicu-
lar biopsy for research purposes only when testicular surgery was
required for the child’s fertility preservation and after obtaining
informed consent.
Testicular tissue was transferred in HBSS on ice to the labora-
tory. It was manually dissected and cut into pieces. The majority of
the collected tissue was used for fertility preservation purposes. For
each donor, a small piece (±1 mm3) fixed in PFA 4% solution (sent
to the laboratory of anatomopathology) served as an ungrafted
control. One fragment of ITT (±1 mm× 1 mm× 3 mm) from
each boy was used for our experiment and divided into three pieces
(±1 mm3) allocated to the three grafting groups.
SLOW-FREEZING AND THAWING
The slow-freezing protocol applied was previously described by
Wyns et al. (4). Briefly, tissue pieces were placed in 1 ml freezing
medium with dimethyl sulfoxide 0.7 M (DMSO, Sigma Aldrich)
and sucrose 0.1 M (Sigma Aldrich) at 4°C in a 2 ml cryovial (Nunc,
Denmark). Using a controlled freezer (Minicool 40 PC Air Liq-
uide, Marne-la-Vallée, France), the vials were maintained at 0°C
for 9 min, cooled at a rate of −0.5°C/min to −8°C and then held
for 5 min before seeding manually at−8°C. After holding for a fur-
ther 15 min at−8°C, a cooling rate of −0.5°C/min was used from
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−8°C to −40°C before final dehydration for 10 min at −40°C.
After cooling at−7°C/min to−80°C, the vials were transferred to
liquid nitrogen (−196°C). For thawing, the cryopreserved tissue
was kept for 2 min at room temperature, thawed in a water bath at
37°C for 2 min, and then washed three times in a reversed sucrose
concentration gradient solution (0.1, 0.05, and 0 M sucrose) for
5 min per bath, using HBSS medium on ice.
XENOGRAFTING
The mice were anesthetized by IP injection of ketamine (75 mg/kg;
Anesketin, Eurovet, Heusden-Zolder, Belgium) and medetomidine
(1 mg/kg; Domitor, Pfizer, CA, USA) dissolved in PBS. They under-
went bilateral castration and, in the course of the same surgery,
a ±1 mm3 piece of donor testicular tissue was grafted without
vascular anastomosis into the scrotum, according to a previously
described procedure (4). After surgery, anesthesia was reversed by
injection of atipamezole (1 mg/kg; Antisedan, Pfizer). Analgesia
was provided by buprenorphine (0.1 mg/kg, Temgesic, Schering
Plough, Kenilworth, NJ, USA) on the day of surgery and the follow-
ing day. In group B, the fragment was placed in a supplementary
bath containing HBSS+ 30 mg NAC for 5 min before transplanta-
tion. In group C, the mice were given an injection of testosterone
(5 mg/kg) and 1.5 IU FSH before reversing anesthesia.
GRAFT RECOVERY
After 5 days, the mice were anesthetized by IP injection of keta-
mine and euthanized by intracardiac blood puncture. The grafts
were recovered and directly fixed in PFA 4% solution. The totality
of the grafted tissue was used for analysis.
HISTOLOGICAL AND IMMUNOHISTOCHEMICAL ANALYSIS
Histology
After fixation in PFA 4% solution, tissue samples were embedded
in paraffin and cut into 5µm-thick serial sections. One section
every 50µm was stained with hematoxylin-eosin (HE) for histo-
logical evaluation by light microscopy. Subsequent sections were
mounted on Superfrost Plus slides and used for immunohisto-
chemistry. Digital images were captured with a Mirax Midi digital
camera (Zeiss Mirax Midi, Zeiss, Germany).
Seminiferous tubule (ST) integrity was evaluated on HE-
stained sections under a light microscope at 400×magnification.
Tubules were considered intact (score 1) when good adhesion of
cells to the basement membrane, good cell cohesion, and no sclero-
sis were noted. Tubules were considered satisfactory (score 2) when
intratubular cells could still be individualized, despite the presence
of focal necrosis. Finally, tubules were considered damaged (score
3) when complete necrosis was observed (Figure 1M).
Immunohistochemistry
Melanoma-associated antigen 4 (MAGE-A4) mouse anti-human
monoclonal antibody was used to evidence SG. This antibody,
purified from hybridoma 57B, was kindly provided by Giulio
Spagnoli MD (University of Basel, Switzerland) (29).
Ki67 mouse anti-human monoclonal antibody (DAKO M7240)
was used to evaluate intratubular proliferation. Ki67 is a nuclear
antigen associated with cell proliferation and is present through-
out the active cell cycle (late G1, S, G2, and M phases), but absent
in resting cells (G0) (30).
FIGURE 1 | Histological appearance and seminiferous tubule (ST)
scoring.
(Continued)
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FIGURE 1 | Continued
Ungrafted controls are shown in (A,E,I). Slow-frozen grafted tissue (group
A) is shown in (B,F,J). Slow-frozen tissue supplemented with NAC (group B)
is shown in (C,G,K). Slow-frozen tissue supplemented with testosterone
(group C) is shown in (D,H,L). Immature testicular tissue is from boys of 2
(A–D), 8 (E–H), and 14 years of age (I–L). STs considered intact score 1,
STs considered satisfactory score 2, and damaged STs score 3 [shown in
(M)]. Scale bar: 50µm.
Proliferating SG were assessed on serial sections stained for
MAGE-A4 and Ki67.
Cleaved caspase-3 rabbit anti-human polyclonal antibody
(Promega G7481) was used to evidence apoptotic cells resulting
from both intrinsic and extrinsic apoptotic routes (31).
Cleaved caspase-8 rabbit anti-human monoclonal antibody
(Cell Signaling 9496) was used to evidence the extrinsic apoptosis
pathway (32).
For immunostaining, sections were deparaffinized and rehy-
drated. Endogenous peroxidase activity was blocked by incubating
the sections with 0.3% H2O2 for 30 min at room temperature (RT).
After washing under deionized water, sections were placed in
citrate buffer for 75 min at 98°C (antigen retrieval was performed
for all antibodies), followed by incubation at RT with 10% nor-
mal goat serum (NGS, Invitrogen, Merelbeke, Belgium) and 1%
bovine serum albumin (BSA, Invitrogen) to block non-specific
binding sites for 30 min (for MAGE-A4 and Ki67).
The primary antibody (diluted to 1/500 for MAGE-A4, 1/150
for Ki67, 1/100 for caspase-8, and 1/200 for caspase-3) was
added and incubated overnight at 4°C in a humidified cham-
ber. The next day, secondary anti-mouse or anti-rabbit antibody
(EnVision+ System-labeled polymer-HRP; DAKO K4001-K4009)
was added and incubated for 60 min at RT. Diaminobenzidine
(DAKO K3468) was used as a chromogen. Nuclei were counter-
stained with Mayer’s hematoxylin [for detailed protocol, see Ref.
(8)]. For immunohistochemistry, STs with scores 1 and 2 were
evaluated.
Terminal deoxynucleotidyl transferase-mediated dUTP nick
end labeling was used to detect deoxyribonucleic acid (DNA) frag-
mentation, found in apoptotic as well as necrotic cells. Sections
were dewaxed, rehydrated, and washed in deionized water. The
slides were then pretreated with 20 mg/ml of proteinase K solu-
tion (Roche Applied Science 745723) in 10 mM Tris–HCl (pH
7.5) for 30 min at 37°C in a humidified chamber. DNA strand
breaks occurring during the apoptotic process were detected using
the in situ Cell Death Detection Kit, TMR Red (Roche Applied
Science 2156792). After washing with PBS, the slides were incu-
bated with the TUNEL reaction mixture – 50µl enzyme solution
(terminal deoxynucleotidyl transferase) and 450µl label solution
(nucleotide mixture in reaction buffer) – for 60 min at 37°C in
a humidified chamber protected from light, followed by rins-
ing in PBS. They were covered with mounting medium with
4,6-diamino-2-phenylindole (DAPI) (Vector Laboratories). This
special formulation is intended to preserve fluorescence during
prolonged storage and, at the same time, counterstain DNA by
means of DAPI. Human tonsil tissue was used as a positive control,
and negative control sections were incubated with label solution
without enzyme solution. Slides were coverslipped and sealed
around the perimeter with nail polish, stored at 4°C, and protected
from light until examination.
TUNEL-stained and DAPI-counterstained slides were exam-
ined under an inverted fluorescence microscope (Leica; Van Hop-
plynus Instruments). Red fluorescence was visualized in TUNEL-
positive cells using an excitation wavelength in the 520–560 nm
range and by observing the emitted light at a wavelength between
570 and 620 nm. DAPI reached excitation at ±360 nm, and emit-
ted at±460 nm when bound to DNA, producing blue fluorescence
in all nuclei.
STATISTICAL ANALYSIS
Analyses were performed using the JMP 7 program based on
SAS. Data are presented as mean± SD. Statistical significance
between variables was evaluated using the Mann–Whitney U -test.
A p-value of ≤0.05 was considered statistically significant. Com-
parisons were made between groups (control versus each grafting
group and between grafting groups).
RESULTS
GRAFT RECOVERY
The graft recovery rate after 5 days of xenotransplantation was
100%.
HISTOLOGICAL EVALUATION
An average of 465± 299, 965± 433, 897± 777, and 774± 554 STs
were examined on HE sections in non-grafted controls and A, B,
and C grafted groups, respectively. In ungrafted controls, all STs
were considered intact (score 1). In all, 21, 18, and 21% of STs
showed good integrity (score 1), 67, 78, and 69% showed satisfac-
tory integrity (score 2), and 12, 4, and 10% were damaged (score
3) in groups A, B, and C, respectively. ST integrity was not statis-
tically different between the three grafted groups, but a significant
decrease in STs with good integrity was noted between grafted
tissue and ungrafted control tissue (Figure 1).
IMMUNOHISTOCHEMISTRY
Spermatogonial cells
An average of 216± 51, 799± 444, 690± 679, and 481± 309 STs
were analyzed in non-grafted controls and A, B, and C grafted
groups, respectively. SG was identified in all grafts, as evidenced
by MAGE-A4-positive cells. The mean number (Table 1) of SG
per analyzed tubule (scores 1 and 2) was not significantly different
between grafted groups (p≥ 0.05) or between grafted groups and
ungrafted controls (p≥ 0.05) (Figure 2). The SG recovery rate was
67, 63, and 53% in groups A, B, and C, respectively.
Intratubular proliferative activity
An average of 220± 71, 847± 422, 628± 632, and 619± 481
STs were analyzed in non-grafted controls and A, B, and C
grafted groups, respectively. We observed proliferation in all
grafts; this proliferative activity was similar (p≥ 0.05) between
ungrafted controls and group B, but different in groups A and C
(p≤ 0.05), with a mean± SD of proliferating cells per ST of 0± 0,
0.06± 0.12, 0.01± 0.01, and 0.04± 0.06 in non-grafted controls,
slow-frozen grafted tissue, NAC grafted tissue, and testosterone
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Table 1 | Spermatogonial recovery.
Age (years) Ungrafted
control
A B C
14 3.17 3.43 2.94 5.01
8 5.46 2.19 2.70 0.80
9 2.28 2.26 1.33 1.82
15 5.46 4.14 3.84 1.30
2 0.51 0.11 0.25 0.19
2 1.26 0.10 0.41 0.50
Mean±SD 3.02±2.09a 2.04±1.67a 1.91±1.47a 1.60±1.77a
A= slow-frozen and grafted, B= slow-frozen and supplemented with NAC,
C= slow-frozen and supplemented with testosterone.
aNo statistical difference was observed between groups (p≥0.05).
grafted tissue, respectively (Figure 3). In addition, only 2.26, 0,
and 3.2% of proliferating cells were SG in A, B, and C grafted
groups, respectively, the remaining proliferating cells being Sertoli
cells.
Intratubular apoptosis and TUNEL
For cleaved caspase-3 evaluation, an average of 107± 34, 184± 68,
146± 116, and 143± 89 STs were analyzed in non-grafted con-
trols and A, B, and C grafted groups, respectively. Cleaved
capsase-3 activity was similar (p≥ 0.05) between groups, show-
ing positive staining (0.21± 0.25, 0.11± 0.14, and 0.11± 0.07
cells) in groups A, B, and C, respectively (Figure 4). No stain-
ing was found in non-grafted controls. In addition, within the
total number of STs analyzed (score 1 and 2), 11.65± 6.75%,
10± 9.75%, and 8.72± 4.77% showed cleaved caspase-3 activity,
with no statistically significant difference between grafted groups
(p≥ 0.05).
For cleaved caspase-8 evaluation, no immunostaining was evi-
denced in any of the groups. Positive and negative controls were
performed on human lymph nodes.
For TUNEL, an average of 104± 21, 74± 27, 54± 30, and
40± 17 STs were analyzed in non-grafted controls and A, B, and
C grafted groups, respectively. A similar mean value (p≥ 0.05) of
75.26± 20.61%, 70.60± 12.81%, and 83.35± 5.76% of positive
STs were observed in A, B, and C grafted groups, respectively. A sta-
tistically significant difference between cleaved caspase-3-positive
tubules and TUNEL-positive tubules was observed in all grafted
groups (p≤ 0.05).
DISCUSSION
Although still experimental, cryopreservation of ITT is a promis-
ing technique to preserve fertility in children. In animals, cryop-
reservation by slow-freezing or vitrification has proved effective in
reinitiating spermatogenesis after tissue transplantation (33–43)
and yielded healthy offspring in some species (35, 36, 41, 43). By
contrast, while survival of human ITT after cryopreservation has
been demonstrated in several studies (4–8, 44, 45), SG recovery
was very low and no normal differentiation was achieved after
several months of transplantation (5–8).
In a previous study, we compared two ITT cryopreservation
protocols: slow-freezing and vitrification. Both showed equivalent
FIGURE 2 | Presence of spermatogonial cells evidenced by MAGE-A4
antibody. Ungrafted controls are shown in (A,E,I). Slow-frozen grafted
tissue (group A) is shown in (B,F,J). Slow-frozen tissue supplemented with
NAC (group B) is shown in (C,G,K). Slow-frozen tissue supplemented with
testosterone (group C) is shown in (D,H,L). Immature testicular tissue is
from boys of 2 (A–D), 8 (E–H), and 14 years of age (I–L). Scale bar: 50µm.
results in terms of SG survival and maturation up to the pachytene
stage. Unexpectedly, SG loss was similar in non-cryopreserved
tissue after transplantation (8), suggesting that there may be
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FIGURE 3 | Proliferative activity evidenced by Ki67 antibody. Ungrafted
controls are shown in (A,E,I). Slow-frozen grafted tissue (group A) is shown
in (B,F,J). Slow-frozen tissue supplemented with NAC (group B) is shown in
(C,G,K). Slow-frozen tissue supplemented with testosterone (group C) is
shown in (D,H,L). Immature testicular tissue is from boys of 2 (A–D), 8
(E–H), and 14 years of age (I–L). Scale bar: 50µm.
FIGURE 4 | Apoptotic activity evidenced by cleaved caspase-3
antibody. Ungrafted controls are shown in (A,E,I). Slow-frozen grafted
tissue (group A) is shown in (B,F,J). Slow-frozen tissue supplemented with
NAC (group B) is shown in (C,G,K). Slow-frozen tissue supplemented with
testosterone (group C) is shown in (D,H,L). Immature testicular tissue is
from boys of 2 (A–D), 8 (E–H), and 14 years of age (I–L). Scale bar:
50µm.
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other causes of poor transplantation outcome apart from the
cryopreservation protocol applied.
While a significant decrease in the number of STs with good
integrity and in SG recovery was noted between the non-grafted
control group and all grafted groups, the number of SG per ST with
good integrity in the grafted groups was not different from the
ungrafted control group, suggesting irreversible damage to some
STs. The SG recovery rate of 53–67% after 5 days is consistent with
the progressive loss seen in our previous studies, where 14.5 and
3.7% of residual SG were observed after 3 weeks and 6 months
of xenografting, respectively (4, 5, 8). It, therefore, appears that
most SG loss occurs early during the grafting process, and hence
before revascularization at 5 days and stabilization of neovessels at
21 days (11).
Interestingly, ST integrity did not worsen over time concomi-
tantly with SG loss. Indeed, 5 days after grafting, only 18.6–21%
of STs appeared to be intact, by contrast with our previous studies
in the same model (4, 5), where the percentage of intact STs was
not statistically different from ungrafted controls (82.19± 16.46%
of intact STs at 3 weeks). We may, therefore, hypothesize that STs
partially recover from the initial insult, but that only empty SSC
niches remain or that there are some irreversible effects on SSC
potential (i.e., their renewal capacity).
To support the latter hypothesis, we previously observed that
intratubular proliferation was mainly due to Sertoli cell prolifer-
ation and not SG (98.87 versus 1.13% proliferating SG) 3 weeks
after xenografting (4). Consistent with these data, we found that
the majority of proliferating cells in grafted tissue were Sertoli
cells, with 97.74, 100, and 96.8% proliferating Sertoli cells com-
pared to 2.26, 0, and 3.2% proliferating SG for groups A, B, and C,
respectively.
This could imply that either induced ischemic cellular stress
and/or an inappropriate graft environment could potentially
enhance recruitment of SSCs entering into the differentiation
process, leading to depletion of the pool of SSCs capable of
auto-renewal, which may be associated with the “burn-out” the-
ory suggested for loss of the follicular reserve after cellular stress
induced by chemotherapy in the ovary (46). An important issue
to determine is to what extent this process occurs and if we may
limit SG depletion by protective molecule supplementation.
We observed a slight but statistically significant increase in
intratubular proliferation (Ki67) in slow-frozen controls and
testosterone-supplemented grafts compared to ungrafted controls.
However, for the group supplemented with NAC, this finding was
not statistically significant, confirming the efficacy of our supple-
mentation, since NAC is a known inhibitor of cell proliferation
(13, 47, 48).
While it is known that maintenance and development of the
graft depend on the hormonal environment (20), the influence of
testosterone on xenograft outcome has not yet been investigated.
In vitro culture of ST sections supplemented with testosterone
showed suppression of apoptosis in human germ cells, confirming
the crucial role of testosterone in germ cell survival (26). Further-
more, in the culture of segments of STs, testosterone withdrawal
coincided with a progressive increase in the proportion of Sertoli
cells showing apoptosis-related DNA fragmentation, independent
of the addition of FSH (49). However, in our study, in vivo sup-
plementation of xenografts with testosterone did not provoke any
decrease in intratubular apoptosis.
Evaluation of apoptosis by detection of activated caspase-3
revealed a significant increase in positive cells in all three grafted
groups compared to the ungrafted control group. Interestingly,
a statistically significant difference between cleaved caspase-3-
positive tubules and TUNEL-positive tubules was observed in
each grafted group (p≤ 0.05). With TUNEL staining shown to be
predominant over cleaved caspase-3, we can conclude that necro-
sis is responsible for most of the irreversible damage to STs and
SG, rather than apoptosis. ST necrosis due to initial hypoxia, as
opposed to apoptosis, appears to be implicated in low SG recovery.
Addition of NAC at the tested concentration failed to demon-
strate any beneficial effect on SG or ST preservation. By contrast,
two studies have shown an anti-apoptotic effect of NAC in testic-
ular tissue. Indeed, administration of NAC by IP injection in rats
prevented male germ cell death from exposure to toxic methoxy-
acetic acid (50) and reduced apoptosis in mice when apoptosis was
induced by human chorionic gonadotropin (51). The difference
between these study results may be attributed to the absence of ini-
tial vascularization of the ITT, since transplantation was achieved
without vascular anastomosis in our study and was thus depen-
dent on neoangiogenesis, or a more limited anti-proliferative effect
of NAC on SG cell proliferation in previous studies. We cannot
fully ascertain the absence of effect at a higher concentration,
as increased levels were demonstrated to have an impact in the
presence of a vascular network.
We hypothesize that oxidative stress during the avascular
period could also induce Sertoli cell injury and consequently
lead to germ cell apoptosis. It has indeed been demonstrated
that Fas expression and apoptosis in germ cells were increased
after ischemia/reperfusion and that injection of anti-Fas antibody
proved effective in decreasing apoptosis in these cells (52).
Moreover, Sertoli cell injury by exposure to phthalates induces
germ cell apoptosis through the Fas/Fas ligand interaction (53).
To further investigate apoptotic pathways implicated in SG/ST
apoptosis, this extrinsic apoptotic route was analyzed by evidenc-
ing activation of caspase-8, this protein being the first activated
caspase in the extrinsic pathway through the Fas/Fas ligand inter-
action, where Fas ligand is produced by Sertoli cells (31). Since
none of our transplants showed caspase-8 activity, there is so far
no evidence that Sertoli cells are directly implicated in SG loss in
slow-frozen tissue grafts.
In conclusion, the results obtained in our study did not show
any clear impact of the addition of NAC at the tested concentra-
tion nor testosterone on the survival of germ cells or inhibition
of apoptosis in grafted ITT. The transplantation model used may
play a part in this and constitutes a limitation of the study.
Although we found inhibition of SG proliferation in grafts sup-
plemented with NAC, confirming its effect on grafted tissue, the
time it takes to reach the graft or its concentration in the graft could
be insufficient before reestablishment of vascularization. There-
fore, since in vitro experiments have shown the effect of NAC on
hypoxia to be dose dependent (54), increasing the doses may be
considered.
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Furthermore, since angiogenesis is not completed before day 21
(11), ways of obtaining better distribution of protective molecules,
for more localized action at the tissular level until angiogenesis is
complete, should be investigated.
Further studies to improve transplantation outcomes are, there-
fore, warranted before clinical autotransplantation of stored ITT
can be contemplated.
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